Early Human Development
Volume 86, Issue 5 , Pages 299-304 , May 2010

Neuregulin-1 high-producer genotype is associated with a decreased risk of admission to the neonatal intensive care unit

  • Elizabeth P. Pleickhardt

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • ,
  • Andrew Celandine

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • ,
  • Jonathan M. Davis

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • ,
  • Minghua Chen

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • ,
  • Peter Schürmann

      Affiliations

    • Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany
    • ,
  • Thilo Dörk

      Affiliations

    • Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany
    • ,
  • Christiane E.L. Dammann

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • Department of Pediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany
    • ,
  • Olaf Dammann

      Affiliations

    • Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • Perinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany
    • Neuroepidemiology Unit, Children's Hospital, Boston, MA, USA
    • Corresponding Author InformationCorresponding Author. Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Box 854, 750 Washington St., Boston, MA 02111, USA. Tel.: +1 617 636 0240; fax: +1 617 636 3309.

Received 29 December 2009 ,Revised 12 March 2010 ,Accepted 15 March 2010.

References 

  1. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns — dry numbers, wet lab, and causal inference. Early Hum Dev. 2004;79:1–15
  2. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42:1–8
  3. Dammann O, Leviton A. Brain damage in preterm newborns: might enhancement of developmentally-regulated endogenous protection open a door for prevention?. Pediatrics. 1999;104:541–550
  4. Dammann O, Leviton A. Brain damage in preterm newborns: biologic response modification as a strategy to reduce disabilities. J Pediatr. 2000;136:433–438
  5. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14–30
  6. Britsch S. The neuregulin-1/ErbB signaling system in development and disease. Adv Anat Embryo Cell Biol. 2007;190:1–65
  7. Dawei L, Collier DA, Hi L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Dev. 2006;15:1995–2002
  8. Revillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features, and prognosis. Ann Onc. 2008;19:73–80
  9. Dammann O, Bueter W, Leviton A, Gressens P, Dammann CE. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology. 2007;43:1–6
  10. Dammann CE, Nielsen HC, Carraway KL. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med. 2003;167:1711–1716
  11. Bueter W, Dammann O, Zscheppang K, Korenbaum E, Dammann CE. ErbB receptors in fetal endothelium — a potential linkage point for inflammation-associated neonatal disorders. Cytokine. 2006;36:267–275
  12. Xu Z, Ford GD, Croslan DR, Jiang J, Gates A, Allen R, et al. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis. 2005;19:461–470
  13. Lok J, Wang H, Murata Y, Zhu HH, Qin T, Whalen MJ, et al. Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice. J Neurotrauma. 2007;24:1817–1822
  14. Hoffmann I, Bueter W, Zscheppang K, Brinkhaus MJ, Liese A, Riemke S, et al. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun. 2010;24:784–791
  15. Ferber A, Minior VK, Bornstein E, Divon MY. Fetal “nonreassuring status” is associated with elevation of nucleated red blood cell counts and interleukin-6. Am J Obstet Gynecol. 2005;192:1427–1429
  16. Kassal R, Anwar M, Kashlan F, Smulian J, Hiatt M, Hegyi T. Umbilical vein interleukin-6 levels in very low birth weight infants developing intraventricular hemorrhage. Brain Dev. 2005;27:483–487
  17. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996;174:1433–1440
  18. Harding D, Brull D, Humphries SE, Whitelaw A, Montgomery H, Marlow N. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr Res. 2005;58:117–120
  19. Dordelmann M, Kerk J, Dressler F, Brinkhaus MJ, Bartels DB, Dammann CE, et al. Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study. Neuropediatrics. 2006;37:130–136
  20. Kwong KY, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, et al. The effects of IL-10 on proinflammatory cytokine expression (IL-1beta and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol. 1998;88:105–113
  21. Mesples B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res. 2003;141:25–32
  22. Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, Thigpen B, Cai Z, Rhodes P, et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol. 2004;191:1387–1392
  23. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458–1463
  24. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8
  25. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut. 2004;53:1082–1089
  26. Janeway C, et al. Innate immunity. In: Immunobiology. New York: Garland Publishing; 2001;p. 35–93

PII: S0378-3782(10)00086-1

doi: 10.1016/j.earlhumdev.2010.03.010

Early Human Development
Volume 86, Issue 5 , Pages 299-304 , May 2010

Article Tools

* Image Usage & Resolution